They probably either have designed the primary end-point of phase 3 incorrectly, or
the "phase 3 jinx" has gotten to them again.
Either way, I hope it is only this indication of Gevo that fails; but we probably will learn more
on August 6. Maybe if we're lucky, EyeGuard A and C will have a better outcome.
Well said. That's the golden rule in stock trading.
Also keep in mind that anything is possible. Remember XOMA hasn't fully analysed the data yet...
maybe there's a light at the end of the tunnel.
I'm talking about a rebound that is to stay before it's ready for another leg up, not a quick one like yesterday's.
Sorry..I have to disagree. People were expecting too much, and therefore over-reacted.
Could see a rebound to the $1.40 area. JAHO
More grants will be on their way, I presume...maybe even for Ebola research.
If Etep is approved, a very likely candidate for takeover target.. JMHO
For Amarantus, July 22nd (Wed) is the poster presentation date, two topics on LymPro as
stated in the company's previous PR.
Louis Kirby's topic is under the "biomarkers" category, and Paul Jorgensen's is under
the "Development of New Models and Analysis" category.
Any PR regarding LymPro on or before Wed. is still a possibility. JAHO.
First of all, I am not an expert either. But Secukinumab was tested for noninfectious,"non-Behçet's uveitis";
whereas Gevokizumab was targeted for infectious or non-infectious "Behcet's Disease" patients where back of the eye is affected. There should be a difference between non-Behcet's uveitis and Behcet's uvetitis, shouldn't it?
For those who are doubtful, please read Dr Urano's tweet.
"We have identified three drug targets for Wolfram syndrome in the past two years. These are MANF, Calpain 2, and IRE1."
I know you tr;y to bash on AMBS every chance you can have. But when we talk about PPS, we refer to the closing price...which is at $6.53.
As stated in my previous post, PPS is dead cat prior to AAIC. Right now it is forming a weekly
double bottom. Short term range is around $6.50-7.50 (pre-split .044 - 0.050) If that holds, with
some favorite news, $7.50-9.50 is reachable. Extremely good news at the AAIC will probably carry the PPS over $12.00. JAHO
You'll be lucky if this leg up is just short of $30.0 (my guess is around $29)
Next leg up it'll be around $37-38